Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects With Atopic Dermatitis
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This study is a randomized, intraindividual study to evaluate the short-term efficacy of
triamcinolone acetonide (Aristocort® C) in subjects with atopic dermatitis.